Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.
Condition(s):Parkinson Disease; Multiple System AtrophyLast Updated:November 23, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson Disease; Multiple System AtrophyLast Updated:November 23, 2018Completed
Condition(s):Multiple System AtrophyLast Updated:February 7, 2024Enrolling by invitation
Condition(s):Multiple System AtrophyLast Updated:November 24, 2023Recruiting
Condition(s):Multiple System Atrophy, MSALast Updated:September 25, 2017Completed
Condition(s):Multiple System AtrophyLast Updated:September 26, 2023Active, not recruiting
Condition(s):Multiple System Atrophy; MSA – Multiple System AtrophyLast Updated:January 26, 2023Recruiting
Condition(s):Multiple System Atrophy; Parkinsonism; Multiple System Atrophy, Parkinson VariantLast Updated:May 6, 2021Unknown status
Condition(s):Multiple System Atrophy, Cerebellar Variant (Disorder)Last Updated:September 17, 2019Unknown status
Condition(s):Multiple System AtrophyLast Updated:October 13, 2021Completed
Condition(s):Parkinson’s Disease; Multiple System Atrophy, Parkinson Variant; Multiple System AtrophyLast Updated:December 12, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.